Literature DB >> 10101019

Cox-2-selective inhibitors: the new super aspirins.

D L DeWitt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10101019

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  35 in total

1.  Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

Authors:  Benjamin J Orlando; Daniel R McDougle; Michael J Lucido; Edward T Eng; Leigh Ann Graham; Claus Schneider; David L Stokes; Aditi Das; Michael G Malkowski
Journal:  Arch Biochem Biophys       Date:  2014-02-03       Impact factor: 4.013

2.  In vitro anti-inflammatory activity of Pothos scandens extract in RAW 264.7 cells.

Authors:  Jisu Kim; Seong Hoon Jeong; Woojae Lee; Hyeyoung Min
Journal:  Food Sci Biotechnol       Date:  2017-05-29       Impact factor: 2.391

Review 3.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

4.  The MAP kinase inhibitors, PD098059, UO126 and SB203580, inhibit IL-1beta-dependent PGE(2) release via mechanistically distinct processes.

Authors:  R Newton; L Cambridge; L A Hart; D A Stevens; M A Lindsay; P J Barnes
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

5.  Synthesis and biological evaluation of new benzo-thieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives as potential selective cyclooxygenase-2 inhibitors.

Authors:  Mariarita Barone; Adriana Carol Eleonora Graziano; Agostino Marrazzo; Pietro Gemmellaro; Andrea Santagati; Venera Cardile
Journal:  Mol Divers       Date:  2013-04-26       Impact factor: 2.943

6.  Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1.

Authors:  Gilad Rimon; Ranjinder S Sidhu; D Adam Lauver; Jullia Y Lee; Narayan P Sharma; Chong Yuan; Ryan A Frieler; Raymond C Trievel; Benedict R Lucchesi; William L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

7.  The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.

Authors:  Amy J Johnson; Ao-Lin Hsu; Ho-Pi Lin; Xueqin Song; Ching-Shih Chen
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

8.  Oral bioavailability and pharmacokinetics of DRF-4367, a new COX-2 inhibitor in rats.

Authors:  Mullangi Ramesh; Rao N V S Mamidi; Kota Jagannath; Sunil Kumar Singh; Kalleda Srinivasa Rao; Yeleswarapu Koteswar Rao; Casturi Seshagirirao; Ramanujam Rajagopalan; Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

9.  Role of prostaglandins in spinal transmission of the exercise pressor reflex in decerebrated rats.

Authors:  A J Stone; S W Copp; M P Kaufman
Journal:  Neuroscience       Date:  2014-07-05       Impact factor: 3.590

10.  Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

Authors:  Thota Ganesh; Jianxiong Jiang; Rangaiah Shashidharamurthy; Ray Dingledine
Journal:  ACS Med Chem Lett       Date:  2013-07-11       Impact factor: 4.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.